Slu7-KO 基因敲除小鼠

下单100%中奖,最高可得千元京东卡
复苏/繁育服务
产品名称

Slu7-KO 基因敲除小鼠

产品编号

S-KO-03965

品系全称

C57BL/6JCya-Slu7em1/Cya

品系背景

C57BL/6JCya

品系编号

KOCMP-193116-Slu7-B6J-VA

品系状态

使用本品系发表的文献需注明: Slu7-KO 基因敲除小鼠 mice (Strain S-KO-03965) were purchased from Cyagen.
交付类型
周龄
性别
基因型
数量

基本信息

基因研究概述

质控标准

基因
基因全称
SLU7 splicing factor homolog (S. cerevisiae)
基因别称
D11Ertd730e,D3Bwg0878e
染色体号
Chr 11 (Mouse)
转录本 ID
NCBI: NM_198936 | Ensembl: ENSMUST00000020681
修饰方式
全身性基因敲除
靶向范围
Exon 2~16
敲除长度
~10.6 kb
品系说明
该品系是基于策略设计时的数据库信息制作而成,建议您在购买前查询最新的数据库和相关文献,以获取最准确的表型信息。
表型提示
SLU7,即Splicing factor synergistic lethal with U5 snRNA 7,是一种在基因表达调控中起着关键作用的剪接因子。SLU7最初被发现对于正确选择3'剪接位点至关重要,对细胞中基因转录的多样性产生重大影响[8]。除了其在剪接中的作用外,SLU7还在基因表达调控的不同层次中发挥着整合中心的作用,包括表观遗传DNA重塑、转录的调节和蛋白质稳定性[1]。SLU7在维持肝脏分化、基因组完整性和细胞周期进展中起着至关重要的作用。因此,SLU7的异常表达与人类疾病有关,包括癌症,尽管它对癌细胞来说是生存的必需因素[1]。此外,SLU7还参与了DNA甲基化过程,维持了DNMT1蛋白的稳定性和DNA甲基化[3]。SLU7对于维持肝脏稳态至关重要,SLU7的敲低会导致细胞分化和代谢功能受损[5]。SLU7通过与STK38相互作用,调节circCAPG的生物发生,并促进TNBC细胞的增殖和转移[2]。此外,SLU7的降解与caspase的激活有关,并导致NMD活性的抑制[4]。SLU7对于维持HNF4α蛋白的稳定性至关重要,并保护肝脏免受氧化损伤[6]。SLU7与SARS-CoV-2 NSP12相互作用,影响病毒复制和基因剪接[7]。SLU7还参与了酵母细胞周期进程中核定位的调控[9]。

参考文献:
1. Gárate-Rascón, María, Recalde, Miriam, Rojo, Carla, Arechederra, María, Berasain, Carmen. 2022. SLU7: A New Hub of Gene Expression Regulation-From Epigenetics to Protein Stability in Health and Disease. In International journal of molecular sciences, 23, . doi:10.3390/ijms232113411. https://pubmed.ncbi.nlm.nih.gov/36362191/
2. Song, Runjie, Guo, Peilan, Ren, Xin, Liu, Jiali, Li, Xiangdong. 2023. A novel polypeptide CAPG-171aa encoded by circCAPG plays a critical role in triple-negative breast cancer. In Molecular cancer, 22, 104. doi:10.1186/s12943-023-01806-x. https://pubmed.ncbi.nlm.nih.gov/37408008/
3. Recalde, Miriam, Gárate-Rascón, María, Elizalde, María, Arechederra, María, Berasain, Carmen. . The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation. In Nucleic acids research, 49, 8592-8609. doi:10.1093/nar/gkab649. https://pubmed.ncbi.nlm.nih.gov/34331453/
4. Rojo, Carla, Gárate-Rascón, María, Recalde, Miriam, Arechederra, María, Berasain, Carmen. 2024. Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis. In JHEP reports : innovation in hepatology, 6, 101118. doi:10.1016/j.jhepr.2024.101118. https://pubmed.ncbi.nlm.nih.gov/39105183/
5. Elizalde, María, Urtasun, Raquel, Azkona, María, Ávila, Matías A, Berasain, Carmen. 2014. Splicing regulator SLU7 is essential for maintaining liver homeostasis. In The Journal of clinical investigation, 124, 2909-20. doi:10.1172/JCI74382. https://pubmed.ncbi.nlm.nih.gov/24865429/
6. Gárate-Rascón, María, Recalde, Miriam, Jimenez, Maddalen, Arechederra, María, Berasain, Carmen. 2021. Splicing Factor SLU7 Prevents Oxidative Stress-Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver Damage. In Hepatology (Baltimore, Md.), 74, 2791-2807. doi:10.1002/hep.32029. https://pubmed.ncbi.nlm.nih.gov/34170569/
7. Yang, Li, Zeng, Xiao-Tao, Luo, Rong-Hua, Zheng, Yong-Tang, Cheng, Wei. . SARS-CoV-2 NSP12 utilizes various host splicing factors for replication and splicing regulation. In Journal of medical virology, 96, e29396. doi:10.1002/jmv.29396. https://pubmed.ncbi.nlm.nih.gov/38235848/
8. Frank, D, Guthrie, C. . An essential splicing factor, SLU7, mediates 3' splice site choice in yeast. In Genes & development, 6, 2112-24. doi:. https://pubmed.ncbi.nlm.nih.gov/1427075/
9. Krishnan, Vishnu Priya, Negi, Manendra Singh, Peesapati, Raghavaram, Vijayraghavan, Usha. 2024. Cryptococcus neoformans Slu7 ensures nuclear positioning during mitotic progression through RNA splicing. In PLoS genetics, 20, e1011272. doi:10.1371/journal.pgen.1011272. https://pubmed.ncbi.nlm.nih.gov/38768219/